🇺🇸 FDA
Patent

US 12037607

Methods of preparing hematopoietic progenitor cells in vitro

granted A61KA61K35/28A61K40/10

Quick answer

US patent 12037607 (Methods of preparing hematopoietic progenitor cells in vitro) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K35/28, A61K40/10, A61K40/40